Liz Barrett

Track

Insider profile

Currently holds positions in Novartis AG, SAGE Therapeutics Inc and Urogen Pharma Ltd

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -51%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
CEO, Novartis Oncology Novartis AG Feb. 1, 2018 -
Independent Director SAGE Therapeutics Inc Jan. 23, 2019 -
President, Chief Executive Officer, Director Urogen Pharma Ltd Jan. 3, 2019 -
Liz Barrett's trades of Urogen Pharma Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
88.64
Quantity 93,350 +37.7%
Value US$3,287,445
Transaction date
Sale
Price
211.95
Quantity 50,468 -2.0%
Value US$3,964,387
Transaction date
Sale
Price
15.72
Quantity 85,837 -26.3%
Value US$1,321,302
Transaction date
Purchase
Price
18.50
Quantity 10,000 +4.6%
Value US$185,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-02 2022-01-31
S Sale
93,350 +37.7%
88.64
US$3,287,445 		93,350 +37.7% 88.64 US$3,287,445
2022-02-02 2022-01-31
S Sale
50,468 -2.0%
211.95
US$3,964,387 		50,468 -2.0% 211.95 US$3,964,387
2022-01-07 2022-01-04
S Sale
85,837 -26.3%
15.72
US$1,321,302 		85,837 -26.3% 15.72 US$1,321,302
2020-12-15 2020-12-14
B Purchase
10,000 +4.6%
18.50
US$185,000 		10,000 +4.6% 18.50 US$185,000